PD-L1, PARP1, and MMRs as potential therapeutic biomarkers for neuroendocrine cervical cancer

Xiaoyu Ji1, Lei Sui1, Kejuan Song1

  • 1Department of Obstetrics and Gynecology, The Affiliated Hospital of Qingdao University, Qingdao, China.

Cancer Medicine
|June 2, 2021
PubMed
Abstract

Related Concept Videos